Demographic and Clinical Factors Associated With Diagnostic Confidence in Interstitial Lung Disease

Mary Beth Scholand MD , Sachin Gupta MD , Kevin R. Flaherty MD , Rosalinda V. Ignacio MS , Zhongze Li MS , Ayodeji Adegunsoye MD
{"title":"Demographic and Clinical Factors Associated With Diagnostic Confidence in Interstitial Lung Disease","authors":"Mary Beth Scholand MD ,&nbsp;Sachin Gupta MD ,&nbsp;Kevin R. Flaherty MD ,&nbsp;Rosalinda V. Ignacio MS ,&nbsp;Zhongze Li MS ,&nbsp;Ayodeji Adegunsoye MD","doi":"10.1016/j.chpulm.2024.100084","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Accurate diagnosis of interstitial lung disease (ILD) can be challenging. Accordingly, clinicians may attribute a diagnostic certainty based on guideline criteria and clinical judgment. However, further research is needed to refine this approach and improve diagnostic clarity.</div></div><div><h3>Research Question</h3><div>What are the real-world factors associated with diagnostic confidence in fibrotic ILD?</div></div><div><h3>Study Design and Methods</h3><div>Data were included from all patients enrolled in the Pulmonary Fibrosis Foundation Patient Registry from March 2016 to August 2018. Baseline demographic and clinical characteristics were collected at enrollment, or at the test date closest to the date of consent for longitudinal measures. Descriptive analyses were performed separately for all participants, and for subgroup participants with idiopathic pulmonary fibrosis (IPF) and participants with non-IPF ILD, stratified by the level of investigator diagnostic confidence (high vs medium/low) assigned at registry enrollment. Adjusted ORs and 95% CIs were calculated using multivariable logistic regression, with the aforementioned characteristics as predictors.</div></div><div><h3>Results</h3><div>Data up to April 2022 from 1,992 participants were included. In adjusted logistic regression analyses among all participants, antifibrotic use (OR, 1.51; 95% CI, 1.09-2.07), longer time since diagnosis (OR, 0.94; 95% CI, 0.89-0.98) at the research unit of 365 days, and diabetes (OR, 2.56; 95% CI, 1.01-6.44) were significantly associated with higher diagnostic confidence, and non-IPF idiopathic interstitial pneumonia (vs IPF; OR, 0.36; 95% CI, 0.24-0.55), insurance - other (OR, 0.65; 95% CI, 0.43-0.97), and Hispanic ethnicity (OR, 0.54; 95% CI, 0.31-0.94) were significantly associated with lower diagnostic confidence. Factors associated with diagnostic confidence in the IPF and/or non-IPF ILD groups included age, male sex, region, immunomodulatory medication use, multidisciplinary team discussion, surgical lung biopsy, and definite high-resolution CT pattern.</div></div><div><h3>Interpretation</h3><div>These findings suggest that certain demographic and clinical factors may influence physicians’ confidence in diagnosis of IPF and non-IPF ILD. Tailored physician education may help to reduce biases and improve consistency in diagnosis.</div></div>","PeriodicalId":94286,"journal":{"name":"CHEST pulmonary","volume":"2 4","pages":"Article 100084"},"PeriodicalIF":0.0000,"publicationDate":"2024-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CHEST pulmonary","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949789224000503","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Accurate diagnosis of interstitial lung disease (ILD) can be challenging. Accordingly, clinicians may attribute a diagnostic certainty based on guideline criteria and clinical judgment. However, further research is needed to refine this approach and improve diagnostic clarity.

Research Question

What are the real-world factors associated with diagnostic confidence in fibrotic ILD?

Study Design and Methods

Data were included from all patients enrolled in the Pulmonary Fibrosis Foundation Patient Registry from March 2016 to August 2018. Baseline demographic and clinical characteristics were collected at enrollment, or at the test date closest to the date of consent for longitudinal measures. Descriptive analyses were performed separately for all participants, and for subgroup participants with idiopathic pulmonary fibrosis (IPF) and participants with non-IPF ILD, stratified by the level of investigator diagnostic confidence (high vs medium/low) assigned at registry enrollment. Adjusted ORs and 95% CIs were calculated using multivariable logistic regression, with the aforementioned characteristics as predictors.

Results

Data up to April 2022 from 1,992 participants were included. In adjusted logistic regression analyses among all participants, antifibrotic use (OR, 1.51; 95% CI, 1.09-2.07), longer time since diagnosis (OR, 0.94; 95% CI, 0.89-0.98) at the research unit of 365 days, and diabetes (OR, 2.56; 95% CI, 1.01-6.44) were significantly associated with higher diagnostic confidence, and non-IPF idiopathic interstitial pneumonia (vs IPF; OR, 0.36; 95% CI, 0.24-0.55), insurance - other (OR, 0.65; 95% CI, 0.43-0.97), and Hispanic ethnicity (OR, 0.54; 95% CI, 0.31-0.94) were significantly associated with lower diagnostic confidence. Factors associated with diagnostic confidence in the IPF and/or non-IPF ILD groups included age, male sex, region, immunomodulatory medication use, multidisciplinary team discussion, surgical lung biopsy, and definite high-resolution CT pattern.

Interpretation

These findings suggest that certain demographic and clinical factors may influence physicians’ confidence in diagnosis of IPF and non-IPF ILD. Tailored physician education may help to reduce biases and improve consistency in diagnosis.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
与间质性肺病诊断可信度相关的人口统计学和临床因素:肺纤维化基金会患者登记处的调查结果
背景间质性肺病(ILD)的准确诊断具有挑战性。因此,临床医生可能会根据指南标准和临床判断来确定诊断的确定性。然而,还需要进一步的研究来完善这种方法并提高诊断的明确性。研究问题与纤维化 ILD 诊断可信度相关的真实世界因素有哪些?研究设计和方法纳入了 2016 年 3 月至 2018 年 8 月期间肺纤维化基金会患者登记处登记的所有患者数据。基线人口统计学和临床特征在入组时收集,纵向测量则在最接近同意日期的测试日期收集。对所有参与者、特发性肺纤维化(IPF)亚组参与者和非 IPF ILD 参与者分别进行了描述性分析,并根据注册登记时调查者的诊断信心水平(高 vs 中/低)进行了分层。以上述特征为预测因素,采用多变量逻辑回归法计算调整后的ORs和95% CI。在对所有参与者进行调整后的逻辑回归分析中,使用抗纤维化药物(OR,1.51;95% CI,1.09-2.07)、在研究单位诊断时间较长(OR,0.94;95% CI,0.89-0.98)(365 天)和糖尿病(OR,2.56;95% CI,1.01-6.44)与较高的诊断率显著相关。44)与较高的诊断信心明显相关,而非 IPF 特发性间质性肺炎(vs IPF;OR,0.36;95% CI,0.24-0.55)、保险-其他(OR,0.65;95% CI,0.43-0.97)和西班牙裔(OR,0.54;95% CI,0.31-0.94)与较低的诊断信心明显相关。与 IPF 和/或非 IPF ILD 组诊断信心相关的因素包括年龄、男性、地区、免疫调节药物的使用、多学科团队讨论、外科肺活检和明确的高分辨率 CT 模式。有针对性的医生教育可能有助于减少偏倚并提高诊断的一致性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Association of Male Sex With Worse Right Ventricular Function and Survival in Pulmonary Hypertension in the Redefining Pulmonary Hypertension Through Pulmonary Vascular Disease Phenomics Cohort Adapting the Tools of Our Trade Dynamic Digital Radiography Pulmonary Function Testing Annual Adherence of Asian American Individuals in a Lung Cancer Screening Program Compared With Other Racial Groups Strategies for the Management of a Pulmonary Function Laboratory
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1